170 related articles for article (PubMed ID: 35745507)
1. Octaarginine Improves the Efficacy of Nitazoxanide against
Nguyen-Ho-Bao T; Ambe LA; Berberich M; Hermosilla C; Taubert A; Daugschies A; Kamena F
Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745507
[TBL] [Abstract][Full Text] [Related]
2. Systemic efficacy on
Diawara EH; François A; Stachulski AV; Razakandrainibe R; Costa D; Favennec L; Rossignol JF; Gargala G
Parasitology; 2021 Jul; 148(8):975-984. PubMed ID: 33775260
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment and novel drug target against Cryptosporidium.
Gargala G
Parasite; 2008 Sep; 15(3):275-81. PubMed ID: 18814694
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
5. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
[TBL] [Abstract][Full Text] [Related]
6.
Gattan HS; Wakid MH; Qahwaji RM; Altwaim S; Mahjoub HA; Alfaifi MS; Elshazly H; Al-Megrin WAI; Alshehri EA; Elshabrawy HA; El-Kady AM
Front Vet Sci; 2024; 11():1374116. PubMed ID: 38515537
[TBL] [Abstract][Full Text] [Related]
7. On-target inhibition of Cryptosporidium parvum by nitazoxanide (NTZ) and paclitaxel (PTX) validated using a novel MDR1-transgenic host cell model and algorithms to quantify the effect on the parasite target.
Yang B; Yan Y; Wang D; Zhang Y; Yin J; Zhu G
PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011217. PubMed ID: 36972284
[TBL] [Abstract][Full Text] [Related]
8. Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.
Doumbo O; Rossignol JF; Pichard E; Traore HA; Dembele TM; Diakite M; Traore F; Diallo DA
Am J Trop Med Hyg; 1997 Jun; 56(6):637-9. PubMed ID: 9230795
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Commercially Available
Gaber M; Galal LAA; Farrag HMM; Badary DM; Alkhalil SS; Elossily N
Infect Drug Resist; 2022; 15():171-182. PubMed ID: 35087280
[TBL] [Abstract][Full Text] [Related]
10. Dual mechanism (sunlight/dark) of the self-assembly nitazoxanide drug on cellulose nanocrystal surface for destroying the Cryptosporidium parvum oocysts.
Khaleil SR; Mira NM; Ghanem NF; M El-Mehasseb I; Helal IB; El-Shafai NM
Int J Biol Macromol; 2023 Aug; 247():125823. PubMed ID: 37453638
[TBL] [Abstract][Full Text] [Related]
11. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
[No Abstract] [Full Text] [Related]
12. Efficacy of clofazimine and nitazoxanide combination in treating intestinal cryptosporidiosis and enhancing intestinal cellular regeneration in immunocompromised mice.
Esmat M; Abdel-Aal AA; Shalaby MA; Badawi M; Elaskary H; Yousif AB; Fahmy MA
Food Waterborne Parasitol; 2022 Jun; 27():e00161. PubMed ID: 35601881
[No Abstract] [Full Text] [Related]
13. Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.
Gattan HS; Fouad SS; Ellisy RA; Elshazly H; El-Kady AM
J Parasit Dis; 2024 Jun; 48(2):370-380. PubMed ID: 38840881
[TBL] [Abstract][Full Text] [Related]
14.
El-Wakil ES; Abdelmaksoud HF; Wakid MH; Alsulami MN; Hammam O; Albohiri HH; Ghallab MMI
Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375825
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth.
Bessoff K; Sateriale A; Lee KK; Huston CD
Antimicrob Agents Chemother; 2013 Apr; 57(4):1804-14. PubMed ID: 23380723
[TBL] [Abstract][Full Text] [Related]
16. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
Morales Gomez MA
Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.
Love MS; Beasley FC; Jumani RS; Wright TM; Chatterjee AK; Huston CD; Schultz PG; McNamara CW
PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005373. PubMed ID: 28158186
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of proton pump inhibitor (omeprazole) on cryptosporidiosis
Beshay EVN; Nassef NE; El Shafei OK; Saleh MM; Kora MA; Shalaan FH
J Parasit Dis; 2023 Sep; 47(3):535-549. PubMed ID: 37520212
[TBL] [Abstract][Full Text] [Related]
20.
Khan SM; Zhang X; Witola WH
Front Microbiol; 2021; 12():800293. PubMed ID: 35046922
[No Abstract] [Full Text] [Related]
[Next] [New Search]
